Determinants of long-term survival in patients hospitalized for heart failure

Journal of Cardiovascular Medicine

Volumn 11, Issue 3, 2010, Pages 164-169

  Martínez Sellés, Manuel ^a   Martínez, Esther ^a   Cortés, Marcelino ^a   Prieto, Raquel ^a   Gallego, Laura ^a   Fernández Avilés, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Heart failure; Mortality; Risk stratification

Indexed keywords

ADULT; AGE; AGED; AORTA STENOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PROGNOSIS; RISK FACTOR; STROKE; SURVIVAL TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; STROKE VOLUME; SURVIVORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 76449104048     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328332ea96     Document Type: Article

References (29)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 12:e154-e235.
2. Stewart S, MacIntyre K, Capewell S, McMurray JJV. An ageing population and heart failure: an increasing burden in the 21st century? Heart 2003; 89:49-53.
3. Young JB. The global epidemiology of heart failure. Med Clin North Am 2004; 88:1135-1143.
4. Ryden Bergsten T, Andersson F. The healthcare costs of heart failure in Sweden. J Int Med 1999; 246:275-284.
5. Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999; 20:136-139.
6. Sutton GC. Epidemiological aspects of heart failure. Am Heart J 1990; 6:1538-1540.
7. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290:2581-2587.
8. Huynh BC, Rovner A, Rich MW. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial. Arch Intern Med 2006; 166:1892-1898.
9. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27:65-75.
10. Martinez-Selles M, Garcia Robles JA, Prieto L, Dominguez Munoa M, Frades E, Diaz-Castro O, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 2003; 24:2046-2053.
11. Martinez-Selles M, Garcia Robles JA, Prieto L, Serrano JA, Munoz R, Frades E, et al. Annual rates of admission and seasonal variations in hospitalizations for heart failure. Eur J Heart Fail 2002; 4:779-786.
12. Martinez-Selles M, Garcia Robles JA, Prieto L, Frades E, Munoz R, Diaz Castro O, et al. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function. Rev Esp Cardiol 2002; 55:579-586.
13. Martinez-Selles M, Garcia Robles JA, Prieto L, Dominguez Munoa M, Frades E. Heart failure in the elderly: age-related differences in clinical profile and mortality. Int J Cardiol 2005; 102:55-60.
14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333:1190-1195.
15. Martinez-Selles M. Sex, lies and heart failure. Conceptual mistakes in classification and epidemiology. Ital Heart J 2005; 6:66-72.
16. Martinez-Selles M, Muñoa MD, Martinez E, Garcia Fernandez MA, Garcia E. The influence of sex on right ventricular dysfunction in patients with severely depressed left ventricular ejection fraction. Eur J Heart Fail 2006; 8:400-403.
17. Martinez-Selles M, Dominguez M, Martinez E, Garcia Fernandez MA, Garcia E. Women with left ventricular ejection fraction ≤20% have better prognosis than men. Int J Cardiol 2007; 120:276-278.
18. Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J AmColl Cardiol 1996; 28:1781-1788.
19. Adams KF Jr, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, et al. Gender differences in survival in advanced heart failure: insights from the FIRST study. Circulation 1999; 99:1816-1821.
20. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001; 103:375-380.
21. Ghali JK, Pina IL, Gottlieb SS, Deedwania PC, Wikstrand JC, MERIT-HF Study Group. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002; 105:1585-1591.
22. Ibrahim SA, Burant CJ, Kent Kwoh C. Elderly hospitalized patients with diastolic heart failure: lack of gender and ethnic differences in 18-month mortality rates. J Gerontol A Biol Sci Med Sci 2003; 58:56-59.
23. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. The Framingham Heart Study. Circulation 2003; 107:2920-2925.
24. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000; 21:1238-1245.
25. Folkeringa JR, Crijns HJ, Van Veldhuisen DJ. Prognosis of atrial fibrillation in congestive heart failure. Circulation 2004; 109:e11.
26. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000; 102:1126-1131.
27. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32:695-703.
28. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, et al., Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005; 149:548-557.
29. Egan M, Ionescu A. The pocket echocardiograph: a useful new tool? Eur J Echocardiogr 2008; 9:721-725.